Education
About Us
Working with TipRanks
Follow Us
Owens & Minor (OMI)
NYSE:OMI
OMI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.56 - $16.47
Previous CloseN/A
Volume124.16K
Average Volume (3M)2.11M
Market Cap
$401.67M
Enterprise Value$2.76B
Total Cash (Recent Filing)$38.26M
Total Debt (Recent Filing)$463.98M
Price to Earnings (P/E)―
Beta1.16
Next Earnings
Oct 29, 2025EPS Estimate
0.24Last Dividend Ex-Date
Dec 14, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)0.26
Shares Outstanding77,244,160
10 Day Avg. Volume2,124,083
30 Day Avg. Volume2,113,747
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap6.88
Enterprise Value/Revenue0.32
Enterprise Value/Gross Profit1.39
Enterprise Value/Ebitda-30.46
Forecast
1Y Price Target
$6.12Price Target Upside23.39% Upside
Rating ConsensusHold
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Growth ProspectsOMI experienced solid growth in sleep supplies and double-digit growth in urology and ostomy.
Tax BenefitsOMI might gain large cash tax benefits from OBBBA, which could result in OMI paying little to no cash taxes for the next couple years.
ValuationValuation is supported by a solid cash flow quarter, providing some downside protection for OMI.
Bears Say
Contract LossThe loss of the Kaiser contract is expected to create growth headwinds for OMI in 2026.
Cost ChallengesStranded costs from the P&HS business remain elevated and are expected to increase further, impacting margins negatively.
Market PressuresHeadwinds from a shift in diabetes supplies from the DME channel to the pharmacy channel, pricing pressure across Medicare/Medicaid businesses in general, and another round of competitive bidding are likely to pressure growth.
Owens & Minor News
OMI FAQ
What was Owens & Minor’s price range in the past 12 months?
Owens & Minor lowest stock price was $4.56 and its highest was $16.47 in the past 12 months.
What is Owens & Minor’s market cap?
Owens & Minor’s market cap is $401.67M.
When is Owens & Minor’s upcoming earnings report date?
Owens & Minor’s upcoming earnings report date is Oct 29, 2025 which is in 41 days.
How were Owens & Minor’s earnings last quarter?
Owens & Minor released its earnings results on Aug 11, 2025. The company reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.275 by -$0.015.
Is Owens & Minor overvalued?
According to Wall Street analysts Owens & Minor’s price is currently Undervalued.
Does Owens & Minor pay dividends?
Owens & Minor pays a Quarterly dividend of $0.003 which represents an annual dividend yield of N/A. See more information on Owens & Minor dividends here
What is Owens & Minor’s EPS estimate?
Owens & Minor’s EPS estimate is 0.24.
How many shares outstanding does Owens & Minor have?
Owens & Minor has 77,244,160 shares outstanding.
What happened to Owens & Minor’s price movement after its last earnings report?
Owens & Minor reported an EPS of $0.26 in its last earnings report, missing expectations of $0.275. Following the earnings report the stock price went down -34.697%.
Which hedge fund is a major shareholder of Owens & Minor?
Currently, no hedge funds are holding shares in OMI
Owens & Minor Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$6.12 (23.39% Upside)
$6.12 (23.39% Upside)
Blogger Sentiment
Bullish
OMI Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 260.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $8.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 19.8%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.09%
12-Months-Change
Fundamentals
Return on Equity
-144.11%
Trailing 12-Months
Asset Growth
-21.67%
Trailing 12-Months
Company Description
Owens & Minor
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.
OMI Company Deck
OMI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mix of positive and negative elements. The company highlighted strong growth in the Patient Direct business and improved EBITDA margins. However, challenges included significant costs associated with the Rotech acquisition termination and increased stranded costs, alongside slower-than-expected growth in the diabetes segment. Overall, the sentiment appears balanced with both positive and negative aspects influencing the outlook.View all OMI earnings summariesOMI Stock 12 Month Forecast
Average Price Target
$6.12
▲(23.39% Upside)
Technical Analysis
Ownership Overview
18.67% Insiders
25.56% Mutual Funds
0.21% Other Institutional Investors
26.49% Public Companies and
Individual Investors